30 September 2022
Press releases
Hemarina helps to heal injuries in reconstructive surgery with HEMO2life® oxygen carrier
During his visit to France’s Percy Army Training Hospital on 28 April 2022, The French President met several soldiers who
5 May 2022
Amrita Institute of Medical Sciences (AIMS) in Kochi, India, Becomes the First Hospital in the World to Carry Out Bilateral Upper Limb Transplant using HEMO2life®
HEMO2life® oxygen carrier medical device derived from Arenicola marina lugworm facilitating grafts preservation without delayed graft function opens up new
9 November 2021
HEMARINA awarded the Start-Up of the Year Prize during the Western Region EY Entrepreneur of the Year 2018 ceremony
Morlaix (France), October 19, 2018 – EY has awarded the National Start-Up of the Year Prize to Hemarina and its
1 April 2021
HEMARINA AND DELPHARM TEAM UP TO MANUFACTURE HEMO2life®
Morlaix and Boulogne-Billancourt (France), 29 November 2018 Hemarina and Delpharm today announced the signature of a partnership involving the manufacture
1 April 2021
CORONAVIRUS: HEMARINA’S MOLECULE CAN SAVE LIVES BY REPLACING LIFE-SUPPORT VENTILATORS FOR OXYGENATING PATIENTS WITH COVID-19
Morlaix, Brittany (France), March 23rd 2020 – Day 6 of confinement – Hemarina, a French biotech company, is ready to
31 March 2021
CORONAVIRUS: MONACO TRIAL BASED ON LUGWORM OXYGENATING FEATURES IS SUSPENDED BUT RESEARCH CONTINUES
Morlaix, Brittany (France), April 9th 2020 – Hemarina, the Breton biotech company, acknowledged the ANSM decision to suspend Monaco trial
31 March 2021
NEW DENTAL HEALTH APPLICATION FOR HEMARINA’S M101 MOLECULE PUBLISHED IN SCIENTIFIC REPORTS RESEARCH JOURNAL
Morlaix, Brittany (France) – Sept, 9, 2020 – Hemarina, a biotechnology company based in Brittany, announced today the publication of
31 March 2021
HEMARINA AND BREST UNIVERSITY HOSPITAL (CHRU DE BREST): OXYOP2 CLINICAL TRIAL TO EVALUATE EFFICACY OF UNIVERSAL OXYGEN CARRIER HEMO2LIFE® IN KIDNEY TRANSPLANTS PROCEEDS SUCCESSFULLY IN ALL FRENCH TRANSPLANT CENTERS
Morlaix, Brest (France), 26 November 2020 – Brest University Hospital and Hemarina, a biotech company based in Brittany, announced today
31 March 2021
Categories
- News (7)
- Press releases (9)
- Uncategorized (7)
